These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33768011)

  • 21. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-DT: designing gRNAs for the CRISPR-Cpf1 system with improved target efficiency and specificity.
    Zhu H; Liang C
    Bioinformatics; 2019 Aug; 35(16):2783-2789. PubMed ID: 30615056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
    Soppe JA; Lebbink RJ
    Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
    Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes.
    Ferreira R; Gatto F; Nielsen J
    FEBS Lett; 2017 Oct; 591(20):3288-3295. PubMed ID: 28884816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering guide RNA to reduce the off-target effects of CRISPR.
    Wu J; Yin H
    J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection.
    Wang Q; Liu S; Liu Z; Ke Z; Li C; Yu X; Chen S; Guo D
    Virus Res; 2018 May; 250():21-30. PubMed ID: 29625148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compartmentalized CRISPR Reactions (CCR) for High-Throughput Screening of Guide RNA Potency and Specificity.
    Supakar T; Herring-Nicholas A; Josephs EA
    Small; 2024 Oct; 20(42):e2403496. PubMed ID: 38845060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustered regularly interspaced palindromic repeats-cas9-based strategies towards HIV eradication: A literature review.
    Miranda AV; Wiyono L; Nurachman LA
    J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S134-S139. PubMed ID: 33785958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays.
    Kurata M; Wolf NK; Lahr WS; Weg MT; Kluesner MG; Lee S; Hui K; Shiraiwa M; Webber BR; Moriarity BS
    PLoS One; 2018; 13(9):e0198714. PubMed ID: 30222773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PARA: A New Platform for the Rapid Assembly of gRNA Arrays for Multiplexed CRISPR Technologies.
    Yuan G; Martin S; Hassan MM; Tuskan GA; Yang X
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Planta Processing of the SpCas9-gRNA Complex.
    Mikami M; Toki S; Endo M
    Plant Cell Physiol; 2017 Nov; 58(11):1857-1867. PubMed ID: 29040704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) Vectors.
    Fakhiri J; Nickl M; Grimm D
    Methods Mol Biol; 2019; 1961():111-126. PubMed ID: 30912043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter.
    Zhang JH; Pandey M; Kahler JF; Loshakov A; Harris B; Dagur PK; Mo YY; Simonds WF
    J Biotechnol; 2014 Nov; 189():1-8. PubMed ID: 25193712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9.
    Allen AG; Chung CH; Worrell SD; Nwaozo G; Madrid R; Mele AR; Dampier W; Nonnemacher MR; Wigdahl B
    Front Genome Ed; 2023; 5():1101483. PubMed ID: 37124096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.